News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
240,000 Results
Type
Article (7409)
Company Profile (18)
Press Release (232572)
Multimedia
Podcasts (8)
Webinars (2)
Section
Business (63248)
Career Advice (301)
Deals (14798)
Drug Delivery (32)
Drug Development (36886)
Employer Resources (27)
FDA (6474)
Job Trends (4923)
News (122119)
Policy (11683)
Tag
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
Academia (572)
Accelerated approval (15)
Adcomms (8)
Allergies (68)
Alliances (14859)
ALS (68)
Alzheimer's disease (723)
Antibody-drug conjugate (ADC) (150)
Approvals (6735)
Artificial intelligence (199)
Autoimmune disease (78)
Automation (10)
Bankruptcy (147)
Best Places to Work (4608)
BIOSECURE Act (2)
Biosimilars (64)
Biotechnology (18)
Bladder cancer (115)
Brain cancer (35)
Breast cancer (279)
Cancer (2663)
Cardiovascular disease (173)
Career advice (270)
Career pathing (6)
CAR-T (180)
CDC (10)
Celiac Disease (1)
Cell therapy (409)
Cervical cancer (23)
Clinical research (33477)
Collaboration (644)
Compensation (205)
Complete response letters (20)
COVID-19 (787)
CRISPR (36)
C-suite (302)
Cystic fibrosis (67)
Data (3858)
Denatured (4)
Depression (59)
Diabetes (191)
Diagnostics (2365)
Digital health (12)
Diversity (4)
Diversity, equity & inclusion (10)
Drug discovery (87)
Drug pricing (60)
Drug shortages (19)
Duchenne muscular dystrophy (112)
Earnings (35518)
Editorial (20)
Employer branding (1)
Employer resources (21)
Events (33259)
Executive appointments (347)
FDA (8325)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (570)
Gene editing (88)
Generative AI (18)
Gene therapy (261)
GLP-1 (280)
Government (1308)
Grass and pollen (2)
Guidances (288)
Healthcare (6156)
HIV (33)
Huntington's disease (15)
IgA nephropathy (55)
Immunology and inflammation (82)
Immuno-oncology (25)
Indications (64)
Infectious disease (903)
Inflammatory bowel disease (87)
Inflation Reduction Act (6)
Influenza (52)
Intellectual property (159)
Interviews (46)
IPO (8113)
IRA (20)
Job creations (574)
Job search strategy (221)
JPM (11)
Kidney cancer (12)
Labor market (15)
Layoffs (51)
Leadership (6)
Legal (2109)
Liver cancer (51)
Longevity (3)
Lung cancer (349)
Lymphoma (227)
Machine learning (17)
Management (8)
Manufacturing (286)
MASH (97)
Medical device (4768)
Medtech (4792)
Mergers & acquisitions (7337)
Metabolic disorders (500)
Multiple sclerosis (84)
NASH (8)
Neurodegenerative disease (115)
Neuropsychiatric disorders (33)
Neuroscience (1260)
NextGen: Class of 2026 (1505)
Non-profit (717)
Obesity (206)
Opinion (106)
Ovarian cancer (112)
Pain (95)
Pancreatic cancer (147)
Parkinson's disease (122)
Partnered (11)
Patents (299)
Patient recruitment (296)
Peanut (19)
People (15169)
Pharmaceutical (8)
Pharmacy benefit managers (9)
Phase 1 (10756)
Phase 2 (14741)
Phase 3 (10998)
Pipeline (3239)
Policy (73)
Postmarket research (798)
Preclinical (3938)
Press Release (9)
Prostate cancer (128)
Psychedelics (13)
Radiopharmaceuticals (131)
Rare diseases (391)
Real estate (1019)
Recruiting (8)
Regulatory (10370)
Reports (16)
Research institute (534)
Resumes & cover letters (39)
Rett syndrome (22)
RNA editing (5)
RSV (30)
Schizophrenia (74)
Series A (86)
Series B (78)
Service/supplier (2)
Sickle cell disease (48)
Special edition (2)
Spinal muscular atrophy (34)
Sponsored (17)
Startups (686)
Stomach cancer (6)
Supply chain (39)
Tariffs (12)
The Weekly (3)
Vaccines (291)
Venture capital (18)
Weight loss (109)
Women's health (26)
Worklife (5)
Date
Last 7 days (286)
Last 30 days (1034)
Last 365 days (15014)
2026 (1388)
2025 (15067)
2024 (16933)
2023 (19107)
2022 (22271)
2021 (23654)
2020 (21815)
2019 (14454)
2018 (10645)
2017 (11463)
2016 (9554)
2015 (11751)
2014 (8108)
2013 (5886)
2012 (6060)
2011 (6762)
2010 (6228)
Location
Africa (182)
Alabama (28)
Alaska (2)
Arizona (77)
Arkansas (3)
Asia (18322)
Australia (5016)
California (5677)
Canada (1852)
China (552)
Colorado (221)
Connecticut (299)
Delaware (131)
Europe (29703)
Florida (870)
Georgia (118)
Hawaii (1)
Idaho (7)
Illinois (370)
India (52)
Indiana (202)
Japan (223)
Kansas (23)
Kentucky (10)
Louisiana (11)
Maine (44)
Maryland (634)
Massachusetts (3863)
Michigan (97)
Minnesota (193)
Missouri (63)
Montana (12)
Nebraska (8)
Nevada (79)
New Hampshire (45)
New Jersey (1804)
New Mexico (4)
New York (1668)
North Carolina (608)
North Dakota (2)
Northern California (2803)
Ohio (118)
Oklahoma (2)
Oregon (9)
Pennsylvania (1121)
Puerto Rico (11)
Rhode Island (11)
South America (304)
South Carolina (42)
Southern California (2258)
Tennessee (68)
Texas (877)
United States (19621)
Utah (131)
Virginia (135)
Washington D.C. (21)
Washington State (527)
West Virginia (2)
Wisconsin (25)
Wyoming (1)
240,000 Results for "quotient limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Quotient Therapeutics Appoints Seasoned Life Sciences Executive, Susan Keefe, as Chief Financial Officer
February 2, 2026
·
2 min read
Press Releases
Flagship Pioneering Announces New Agreements with ProFound Therapeutics and Quotient Therapeutics Under its Collaboration with GSK
November 21, 2025
·
5 min read
Press Releases
Quotient Therapeutics Appoints Drug Discovery and Development Veteran, Andrew Bayliffe, as Chief Development Officer
September 30, 2025
·
2 min read
Collaboration
Pfizer Partners With Flagship’s Quotient to Leverage Genetics Against Heart, Renal Diseases
Quotient Therapeutics’ platform targets somatic mutations, which the startup contends can help identify a broader scope of genes potentially associated with disease phenotypes. Wednesday’s agreement is part of an existing partnership between Pfizer and Flagship Pioneering.
August 28, 2024
·
2 min read
·
Tristan Manalac
Press Releases
AABB To Run Limited-Time Certified Advanced Biotherapies Professional (CABP) Free Exam Retake Offer
December 1, 2025
·
1 min read
Press Releases
Haemonetics Acquires Vivasure Medical Limited
January 9, 2026
·
5 min read
Policy
Quotient Limited Announces Intent to Voluntary Delist from the Nasdaq Global Market
Quotient Limited announced that it has given formal notice to the Nasdaq Stock Market LLC of its intention to voluntarily delist its ordinary shares from the Nasdaq Global Market.
December 12, 2022
·
3 min read
Quotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease Diagnostics
Quotient Limited announced an agreement with Theradiag, a market leader in autoimmune disease testing and pioneer in theranostics, under which the two companies will partner to advance autoimmune diagnostics by leveraging Quotient’s MosaiQ platform.
June 8, 2022
·
7 min read
Quotient Limited Selected to Join the World Economic Forum New Champions Community
Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, announced it was selected by the World Economic Forum to join their New Champions Community.
September 8, 2022
·
3 min read
Quotient Limited Announces Intent to Effect Reverse Stock Split
Quotient Limited, a commercial-stage diagnostics company, announced that it will effect a one-for-40 reverse stock split of its ordinary shares, nil par value that will become effective on November 2, 2022 at 5:01 p.m. Eastern Time, after the close of trading on The Nasdaq Global Market.
October 31, 2022
·
3 min read
1 of 24,000
Next
